CONSENT OF CHERRY BEKAERT LLP
Published on February 23, 2016
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference of our firm under the caption Experts in this Amendment No. 1 to the Registration Statement on Form S-1 and related prospectus of Hedgepath Pharmaceuticals, Inc. dated February 23, 2016 and to the inclusion therein of our report, dated February 1, 2016, with respect to the financial statements of Hedgepath Pharmaceuticals, Inc. included in its Form 10-K filed February 1, 2016 with the Securities and Exchange Commission.
/s/ Cherry Bekaert LLP
Tampa, Florida
February 23, 2016